Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: IC31

Valneva – innovative vaccines against infectious diseases

Posted on by

Valneva is a biotech company covering the full value chain from bench to market on innovative vaccines against infectious diseases.

Valneva – innovative vaccines against infectious diseases

valneva

Continue reading →

Posted in Biotech Companies, Biotech Companies Austria, Biotech Companies France, Biotech Companies Japan, Biotech Companies UK, Biotech Companies USA | Tagged Alain MUNOZ, Alexander VON GABAIN, Anne-Marie GRAFFIN, Clostridium difficile, EB66, EB66 vaccine production cell line, Franck GRIMAUD, Frédéric GRIMAUD, Hans WIGZELL, IC31, IC31 adjuvant, infectious disease, infectious diseases, innovative vaccine, innovative vaccine against infectious disease, innovative vaccines against infectious diseases, Intercell, IXIARO, James SULAT, Japanese encephalitis, Japanese encephalitis virus, Japanese encephalitis virus infection, JESPECT, Lyme Borreliosis, Michel GRÉCO, prevention Japanese encephalitis, Pseudomonas aeruginosa, Reinhard KANDERA, Thomas LINGELBACH, Valneva, Valneva - innovative vaccines against infectious diseases, virus infection, Vivalis

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress